These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 35471524)
21. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia. Bassler D Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104 [TBL] [Abstract][Full Text] [Related]
22. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Engle WA; Pediatrics; 2008 Feb; 121(2):419-32. PubMed ID: 18245434 [TBL] [Abstract][Full Text] [Related]
23. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. Tapia JL; Ramírez R; Cifuentes J; Fabres J; Hübner ME; Bancalari A; Mercado ME; Standen J; Escobar M J Pediatr; 1998 Jan; 132(1):48-52. PubMed ID: 9469999 [TBL] [Abstract][Full Text] [Related]
24. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial. Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567 [TBL] [Abstract][Full Text] [Related]
25. Surfactant therapy in premature babies: SurE or InSurE. Jena SR; Bains HS; Pandita A; Verma A; Gupta V; Kallem VR; Abdullah M; Kawdiya A; On Behalf Of Sure Group Pediatr Pulmonol; 2019 Nov; 54(11):1747-1752. PubMed ID: 31424177 [TBL] [Abstract][Full Text] [Related]
26. Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome. Garland JS; Buck RK; Allred EN; Leviton A Arch Pediatr Adolesc Med; 1995 Jun; 149(6):617-22. PubMed ID: 7767415 [TBL] [Abstract][Full Text] [Related]
27. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants. Kaniewska U; Gulczyńska E Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994 [TBL] [Abstract][Full Text] [Related]
28. Pulmonary pathology in surfactant-treated preterm infants with respiratory distress syndrome: an autopsy study. Toti P; Buonocore G; Rinaldi G; Catella AM; Bracci R Biol Neonate; 1996; 70(1):21-8. PubMed ID: 8853843 [TBL] [Abstract][Full Text] [Related]
29. Animal derived surfactant extract for treatment of respiratory distress syndrome. Seger N; Soll R Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695 [TBL] [Abstract][Full Text] [Related]
30. Respiratory management in the premature neonate. Dumpa V; Avulakunta I; Bhandari V Expert Rev Respir Med; 2023 Feb; 17(2):155-170. PubMed ID: 36803028 [TBL] [Abstract][Full Text] [Related]
31. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group. Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230 [TBL] [Abstract][Full Text] [Related]
32. [Treatment of severe respiratory distress syndrome with surfactant]. Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999 [TBL] [Abstract][Full Text] [Related]
33. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. Horbar JD; Soll RF; Sutherland JM; Kotagal U; Philip AG; Kessler DL; Little GA; Edwards WH; Vidyasagar D; Raju TN N Engl J Med; 1989 Apr; 320(15):959-65. PubMed ID: 2648150 [TBL] [Abstract][Full Text] [Related]
34. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470 [TBL] [Abstract][Full Text] [Related]
35. Effect of two different early rescue surfactant treatments on mortality in preterm infants with respiratory distress syndrome. Kadıoğlu Şimşek G; Kanmaz Kutman HG; Canpolat FE; Oğuz ŞS Clin Respir J; 2020 Mar; 14(3):285-290. PubMed ID: 31814293 [TBL] [Abstract][Full Text] [Related]
36. [Surfactant replacement therapy for respiratory distress syndrome: a pilot study]. Shinwell ES; Zmora E; Leven D; Berger I; Karplus M Harefuah; 1992 Jul; 123(1-2):1-4, 72. PubMed ID: 1505835 [TBL] [Abstract][Full Text] [Related]
37. Less-Invasive Surfactant Administration for Neonatal Respiratory Distress Syndrome: A Consensus Guideline. Reynolds P; Bustani P; Darby C; Fernandez Alvarez JR; Fox G; Jones S; Robertson SJ; Vasu V; Roehr CC Neonatology; 2021; 118(5):586-592. PubMed ID: 34515188 [TBL] [Abstract][Full Text] [Related]
38. [Risk factors for minimally invasive surfactant administration failure in preterm infants with respiratory distress syndrome]. Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FQ; Guo W; Li L; Xiao M; Liu WL; Jiang R Zhongguo Dang Dai Er Ke Za Zhi; 2020 Mar; 22(3):231-237. PubMed ID: 32204759 [TBL] [Abstract][Full Text] [Related]
39. Club cell protein expression amongst infants with respiratory distress syndrome. Rallis D; Baltogianni M; Dermitzaki N; Balomenou F; Papastergiou E; Maragoudaki E; Tsabouri S; Makis A; Giapros V Pediatr Pulmonol; 2022 Jun; 57(6):1543-1546. PubMed ID: 35304828 [No Abstract] [Full Text] [Related]
40. Hot topics in and new strategies for surfactant research. Jobe AH Biol Neonate; 1998 Sep; 74 Suppl 1():3-8. PubMed ID: 9730585 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]